Circio Holding ASA (CRNA) - Cash Flow Conversion Efficiency

Latest as of June 2025: 2.069x

Based on the latest financial reports, Circio Holding ASA (CRNA) has a cash flow conversion efficiency ratio of 2.069x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr-25.66 Million ≈ $-2.70 Million USD) by net assets (Nkr-12.40 Million ≈ $-1.30 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See CRNA equity financing ratio to measure how much of total assets are equity-financed.

Circio Holding ASA - Cash Flow Conversion Efficiency Trend (2020–2025)

This chart illustrates how Circio Holding ASA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check CRNA cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Circio Holding ASA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Circio Holding ASA ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
CANAAN INC SP.ADR CL.A
F:35J
N/A
Diana Shipping Inc.
NYSE:DSX
0.030x
Apogee Optocom Co Ltd
TW:6426
0.021x
Future Park Leasehold Property Fund
BK:FUTUREPF
0.037x
Arwana Citramulia Tbk
JK:ARNA
0.104x
China Dongxiang (Group) Co. Ltd
F:4C1
0.001x
China Rare Earth Holdings Limited
F:RAE
-0.063x
Yantai Changyu Pioneer Wine
SHE:200869
0.012x

Annual Cash Flow Conversion Efficiency for Circio Holding ASA (2020–2025)

The table below shows the annual cash flow conversion efficiency of Circio Holding ASA from 2020 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Circio Holding ASA.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Nkr-12.49 Million
≈ $-1.31 Million
Nkr-45.82 Million
≈ $-4.82 Million
3.668x +13.21%
2024-12-31 Nkr-12.51 Million
≈ $-1.32 Million
Nkr-40.53 Million
≈ $-4.27 Million
3.240x +257.97%
2023-12-31 Nkr-98.54 Million
≈ $-10.37 Million
Nkr-89.20 Million
≈ $-9.39 Million
0.905x +102.13%
2022-12-31 Nkr2.57 Million
≈ $270.02K
Nkr-108.84 Million
≈ $-11.45 Million
-42.417x -20647.19%
2021-12-31 Nkr417.73 Million
≈ $43.96 Million
Nkr-85.40 Million
≈ $-8.99 Million
-0.204x +31.25%
2020-12-31 Nkr372.59 Million
≈ $39.21 Million
Nkr-110.79 Million
≈ $-11.66 Million
-0.297x --

About Circio Holding ASA

OL:CRNA Norway Biotechnology
Market Cap
$206.00 Million
Nkr1.96 Billion NOK
Market Cap Rank
#16441 Global
#134 in Norway
Share Price
Nkr8.23
Change (1 day)
-7.32%
52-Week Range
Nkr0.58 - Nkr14.40
All Time High
Nkr676.52
About

Circio Holding ASA, a biotechnology company, develops novel circular RNA and immunotherapy medicines. The company is developing TG01, a cancer vaccine targeting driver mutations, which is in three clinical trials for multiple myeloma, and pancreatic and lung cancer; and circVec circRNA vector platform, a modular genetic cassette for biogenesis of multifunctional circRNAs in human cells. It has a … Read more